PMID- 12226549 OWN - NLM STAT- MEDLINE DCOM- 20030207 LR - 20190607 IS - 1340-3478 (Print) IS - 1340-3478 (Linking) VI - 9 IP - 4 DP - 2002 TI - The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. PG - 178-83 AB - Large-scale clinical trials have demonstrated significant reductions in cardiovascular events following statin therapy. The observed benefit of statin therapy, however, may be greater in these trials than is to be expected from lowering lipid levels alone. In order to clarify the mechanism by which statins prevent cardiovascular events in vascular wall cells, we investigated the changes in gene expression profiles after incubation with atorvastatin or pitavastatin in cultured human umbilical vein endothelial cells using DNA microarrays. Statins affected the expression levels of genes involved in inflammation, coagulation, and vascular constriction. The mRNA levels for interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) decreased after statin treatment. Statins reduced mRNA levels of plasminogen activator inhibitor-1 (PAI-1) and increased the mRNA levels of thrombomodulin. Statins reduced the mRNA levels of endothelin-1 and increased the mRNA levels of nitric oxide synthase-3 (eNOS). These results show that, statins are clinically effective because of their ability to change the gene expression profile of endothelial cells thereby preventing vascular events. FAU - Morikawa, Shigeru AU - Morikawa S AD - Department of Molecular Biology, Research Center for Advanced Science and Technology, University of Tokyo, Meguro, Tokyo, Japan. FAU - Takabe, Wakako AU - Takabe W FAU - Mataki, Chikage AU - Mataki C FAU - Kanke, Toru AU - Kanke T FAU - Itoh, Takahiro AU - Itoh T FAU - Wada, Youichiro AU - Wada Y FAU - Izumi, Akashi AU - Izumi A FAU - Saito, Yasushi AU - Saito Y FAU - Hamakubo, Takao AU - Hamakubo T FAU - Kodama, Tatsuhiko AU - Kodama T LA - eng PT - Journal Article PL - Japan TA - J Atheroscler Thromb JT - Journal of atherosclerosis and thrombosis JID - 9506298 RN - 0 (Heptanoic Acids) RN - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) RN - 0 (Pyrroles) RN - 0 (Quinolines) RN - 0 (RNA, Messenger) RN - 0 (Receptors, LDL) RN - A0JWA85V8F (Atorvastatin) RN - EC 1.1.1.- (Hydroxymethylglutaryl CoA Reductases) RN - M5681Q5F9P (pitavastatin) SB - IM MH - Atorvastatin MH - Blood Coagulation/genetics MH - Cells, Cultured MH - Endothelium, Vascular/cytology/*drug effects/metabolism MH - Heptanoic Acids/*pharmacology MH - Humans MH - Hydroxymethylglutaryl CoA Reductases/genetics MH - Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology MH - Inflammation/genetics MH - Oligonucleotide Array Sequence Analysis MH - Pyrroles/*pharmacology MH - Quinolines/*pharmacology MH - RNA, Messenger/genetics/*metabolism MH - Receptors, LDL/genetics MH - Vasoconstriction/genetics EDAT- 2002/09/13 10:00 MHDA- 2003/02/08 04:00 CRDT- 2002/09/13 10:00 PHST- 2002/09/13 10:00 [pubmed] PHST- 2003/02/08 04:00 [medline] PHST- 2002/09/13 10:00 [entrez] AID - 10.5551/jat.9.178 [doi] PST - ppublish SO - J Atheroscler Thromb. 2002;9(4):178-83. doi: 10.5551/jat.9.178.